Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hymovis intra-articular injections for chronic painful shoulder due to glenohumeral osteoarthritis
ISRCTN12525856Phase 3Completed
- Sponsor
- Fidia Farmaceutici
- Start
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of sodium hyaluronate in glenohumeral osteoarthritis, sponsored by Fidia Farmaceutici. Primary endpoint: Pain during activity. Started Oct 2010; status: completed.
02
Drugs
sodium hyaluronate
03
Conditions
glenohumeral osteoarthritis
Beyond the preview
Go deeper on ISRCTN12525856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12525856.